Search Results 911-920 of 21616 for Inhibition

1. An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC) - Mayo Clinic

   ... inhibitor; Patients with aBCC who have not been diagnosed with BCCNS and who were previously treated with vismodegib as part of Genentech study SHH4476g ...

2. PRT3789 Monotherapy And In Combo W/Docetaxel In Participants W/Advanced Or Metastatic Solid Tumors W/SMARCA4 Mutation - Mayo Clinic

   * Concurrent treatment with strong or moderate CYP3A4 inhibitor or inducer. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility ...

3. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

   Another focus is to determine if this pathway can be targeted in pancreatic cancer using PKD inhibitors ... inhibitor 2A (CDKN2A, p16INK1A) is needed for ...

4. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

   Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in ...

5. A Study to Evaluate Clazakizumab in Patients with Life-threatening COVID-19 Infection (Enrolling by Invitation Only) - Mayo Clinic

   Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable);; Intrauterine device (IUD);; Intrauterine ...

6. Deuruxolitinib (oral route) - Side effects & dosage - Mayo Clinic

   Deuruxolitinib is used to treat alopecia areata (autoimmune disorder that causes patchy hair loss). This medicine is a Janus kinase (JAK) inhibitor that works ...

7. Preventing Anthracycline Cardiovascular Toxicity with Statins (PREVENT) - Mayo Clinic

   Current use of CYP 3A4 inhibitors. These include Clarithromycin, HIV protease inhibitors, Itraconazole, grapefruit juice, Cyclosporine, Rifampin or Digoxin ...

8. Novel Gene Drives Development of Different Types of Ovarian Cancer, Mayo Led Study Finds

   This finding suggests that the activation and inhibition of gene expression by DNA methylation can be as important a factor in cancer as genetic mutations.

9. A Study to Investigate the Effectiveness and Safety of Fenfluramine Hydrochloride as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome - Mayo Clinic

   Subject is receiving concomitant therapy with any of the following: centrally-acting anorectic agents; monoamine-oxidase inhibitors ... inhibition; other ...

10. Lansoprazole (oral route) - Side effects & dosage - Mayo Clinic

    Lansoprazole is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced by the stomach. This medicine is available both over-the ...